Clinical Trial Update: Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology

View source ↗

Summary

A clinical trial investigating soluble biomarkers for pancreatic cancer using an inclusive all-patient methodology is currently in the recruitment phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Pancreatic Neoplasms | Status: RECRUITING